Kronos Bio Inc Asset Turnover Ratio (KRON), as of first quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kronos Bio Inc   (NASDAQ: KRON)
 

Kronos Bio Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Kronos Bio Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.07 in the first quarter (Mar 31 2025)

Within sector 169 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2025, to 3094, from total ranking in the fourth quarter 2024 at 3192.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KRON Asset Turnover Ratio (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Asset Change -35.43 % -38.13 % -36.66 % -36.67 % -36.24 %
Y / Y Revenue Change -26.03 % -0.7 % 158.45 % 44.21 % 106.39 %
Asset Turnover Ratio (TTM) 0.07 0.07 0.06 0.05 0.04
KRON's Total Ranking # 3094 # 3192 # 3239 # 3319 # 2694
Seq. Asset Change -9.92 % -12.47 % -9.07 % -9.93 % -13.68 %
Seq. Revenue Change -17.89 % -4.22 % -11.83 % 6.67 % 10.24 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 170
Healthcare Sector # 475
Overall Market # 3094

Asset Turnover Ratio Statistics
High Average Low
0.07 0.05 0.03
(Mar 31 2025)  




KRON Company Profile • Back to KRON Efficiency Comparisons • Compare KRON Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2025 Assets at quarter ending Mar 31 2025
Invo Fertility Inc   0.23 $ 6.593  Millions$ 28.311  Millions
Adc Therapeutics Sa  0.23 $ 75.817  Millions$ 328.844  Millions
Dariohealth Corp   0.23 $ 26.717  Millions$ 116.643  Millions
Repligen Corp  0.23 $ 650.429  Millions$ 2,844.615  Millions
Geron Corporation  0.23 $ 115.794  Millions$ 512.645  Millions
Cue Biopharma Inc   0.23 $ 7.991  Millions$ 35.396  Millions
Mersana Therapeutics inc   0.22 $ 34.006  Millions$ 151.448  Millions
Iovance Biotherapeutics inc   0.22 $ 212.679  Millions$ 958.151  Millions
Moderna Inc   0.22 $ 3,177.000  Millions$ 14,582.250  Millions
Revvity Inc  0.22 $ 2,769.868  Millions$ 12,736.947  Millions
Profound Medical Corp   0.22 $ 11.862  Millions$ 54.741  Millions
Sintx Technologies Inc   0.22 $ 2.569  Millions$ 11.865  Millions
Retractable Technologies Inc  0.21 $ 33.745  Millions$ 157.146  Millions
Neogen Corporation  0.21 $ 904.315  Millions$ 4,285.608  Millions
Maravai Lifesciences Holdings Inc   0.21 $ 241.856  Millions$ 1,173.455  Millions
Jaguar Health Inc   0.21 $ 11.552  Millions$ 56.203  Millions
Biolife Solutions Inc   0.20 $ 79.416  Millions$ 387.814  Millions
Cervomed Inc   0.20 $ 9.308  Millions$ 45.933  Millions
Ligand Pharmaceuticals Incorporated  0.20 $ 181.292  Millions$ 917.120  Millions
Zymeworks Inc   0.20 $ 93.384  Millions$ 472.850  Millions
Vystar Corporation  0.19 $ 0.111  Millions$ 0.581  Millions
Xoma Royalty Corporation  0.19 $ 42.909  Millions$ 225.162  Millions
X4 Pharmaceuticals Inc  0.19 $ 31.364  Millions$ 166.309  Millions
Theravance Biopharma inc   0.18 $ 65.266  Millions$ 353.969  Millions
Innovative Eyewear Inc   0.18 $ 1.707  Millions$ 9.309  Millions
Alector Inc   0.18 $ 88.339  Millions$ 490.840  Millions
Enanta Pharmaceuticals Inc  0.18 $ 64.463  Millions$ 361.777  Millions
Hyperfine Inc   0.18 $ 11.420  Millions$ 64.569  Millions
Lipocine Inc   0.18 $ 3.813  Millions$ 21.685  Millions
Lipella Pharmaceuticals Inc   0.18 $ 0.520  Millions$ 2.969  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.